Cargando…

The mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: Inhibition of dendritic cell functions via Toll like receptor 9 signaling

Hydroxychloroquine (HCQ) is one of the most commonly prescribed immune-suppressants in treating rheumatoid arthritis (RA). Our previous research showed that HCQ suppressed RA development by inhibiting T follicular helper (Tfh) cells directly. Dendritic cells (DCs) serve as the link between innate an...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Jiaochan, Li, Xing, Luo, Xiaoqing, He, Juan, Huang, Xuechan, Zhou, Qingyou, Han, Yanping, Jie, Hongyu, Zhuang, Jian, Li, Yehao, Yang, Fangyuan, Zhai, Zeqing, Wu, Shufan, He, Yi, Yang, Bin, Sun, Erwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547638/
https://www.ncbi.nlm.nih.gov/pubmed/33049581
http://dx.doi.org/10.1016/j.biopha.2020.110848
_version_ 1783592463106048000
author Han, Jiaochan
Li, Xing
Luo, Xiaoqing
He, Juan
Huang, Xuechan
Zhou, Qingyou
Han, Yanping
Jie, Hongyu
Zhuang, Jian
Li, Yehao
Yang, Fangyuan
Zhai, Zeqing
Wu, Shufan
He, Yi
Yang, Bin
Sun, Erwei
author_facet Han, Jiaochan
Li, Xing
Luo, Xiaoqing
He, Juan
Huang, Xuechan
Zhou, Qingyou
Han, Yanping
Jie, Hongyu
Zhuang, Jian
Li, Yehao
Yang, Fangyuan
Zhai, Zeqing
Wu, Shufan
He, Yi
Yang, Bin
Sun, Erwei
author_sort Han, Jiaochan
collection PubMed
description Hydroxychloroquine (HCQ) is one of the most commonly prescribed immune-suppressants in treating rheumatoid arthritis (RA). Our previous research showed that HCQ suppressed RA development by inhibiting T follicular helper (Tfh) cells directly. Dendritic cells (DCs) serve as the link between innate and acquired immunity. Whether HCQ suppressed Tfh cell through DCs was not clear. In current study, we found that HCQ efficiently inhibited CD86, chemokine (C-X-C motif) receptor 4 (CXCR4) expression and interferon-α (IFN-α) secretion of healthy donor derived purified DCs stimulated by RA patient serum. To mimic RA, collagen-induced arthritis (CIA) mouse model was used and treated with HCQ daily for fifty-four days prior to sacrifice. We found HCQ inhibited DC maturation and migration to lymph nodes (LNs), manifested as down-regulated expression of CD40, CD80, CD86, MHCII (I-A(q)) on LN DCs. In addition, HCQ reduced the level of chemokine receptor 7 (CCR7) and L-selectin on peripheral blood DCs and diminished percentage of LN DCs. Of note, HCQ only inhibited CpG ODN 1826-induced IL-12 secretion by bone marrow DCs (BMDCs) stimulated by various toll like receptor (TLR) agonists. Mechanistically, HCQ down-regulated the expression of TLR9 not only in healthy donor PBMC-derived DCs stimulated by RA patient serum, but also in LN DCs of CIA mice and CpG-activated BMDCs. Furthermore, arthritis scores in TLR9(−/−) mice were much lower than that in wild type mice with impaired maturity and migration capability of DCs. Collectively, activation of DCs contributes to the pathogenesis of RA and HCQ shows protective effects on RA by inhibition of DC activation via blocking TLR9.
format Online
Article
Text
id pubmed-7547638
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Authors. Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-75476382020-10-13 The mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: Inhibition of dendritic cell functions via Toll like receptor 9 signaling Han, Jiaochan Li, Xing Luo, Xiaoqing He, Juan Huang, Xuechan Zhou, Qingyou Han, Yanping Jie, Hongyu Zhuang, Jian Li, Yehao Yang, Fangyuan Zhai, Zeqing Wu, Shufan He, Yi Yang, Bin Sun, Erwei Biomed Pharmacother Original Article Hydroxychloroquine (HCQ) is one of the most commonly prescribed immune-suppressants in treating rheumatoid arthritis (RA). Our previous research showed that HCQ suppressed RA development by inhibiting T follicular helper (Tfh) cells directly. Dendritic cells (DCs) serve as the link between innate and acquired immunity. Whether HCQ suppressed Tfh cell through DCs was not clear. In current study, we found that HCQ efficiently inhibited CD86, chemokine (C-X-C motif) receptor 4 (CXCR4) expression and interferon-α (IFN-α) secretion of healthy donor derived purified DCs stimulated by RA patient serum. To mimic RA, collagen-induced arthritis (CIA) mouse model was used and treated with HCQ daily for fifty-four days prior to sacrifice. We found HCQ inhibited DC maturation and migration to lymph nodes (LNs), manifested as down-regulated expression of CD40, CD80, CD86, MHCII (I-A(q)) on LN DCs. In addition, HCQ reduced the level of chemokine receptor 7 (CCR7) and L-selectin on peripheral blood DCs and diminished percentage of LN DCs. Of note, HCQ only inhibited CpG ODN 1826-induced IL-12 secretion by bone marrow DCs (BMDCs) stimulated by various toll like receptor (TLR) agonists. Mechanistically, HCQ down-regulated the expression of TLR9 not only in healthy donor PBMC-derived DCs stimulated by RA patient serum, but also in LN DCs of CIA mice and CpG-activated BMDCs. Furthermore, arthritis scores in TLR9(−/−) mice were much lower than that in wild type mice with impaired maturity and migration capability of DCs. Collectively, activation of DCs contributes to the pathogenesis of RA and HCQ shows protective effects on RA by inhibition of DC activation via blocking TLR9. The Authors. Published by Elsevier Masson SAS. 2020-12 2020-10-10 /pmc/articles/PMC7547638/ /pubmed/33049581 http://dx.doi.org/10.1016/j.biopha.2020.110848 Text en © 2020 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Han, Jiaochan
Li, Xing
Luo, Xiaoqing
He, Juan
Huang, Xuechan
Zhou, Qingyou
Han, Yanping
Jie, Hongyu
Zhuang, Jian
Li, Yehao
Yang, Fangyuan
Zhai, Zeqing
Wu, Shufan
He, Yi
Yang, Bin
Sun, Erwei
The mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: Inhibition of dendritic cell functions via Toll like receptor 9 signaling
title The mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: Inhibition of dendritic cell functions via Toll like receptor 9 signaling
title_full The mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: Inhibition of dendritic cell functions via Toll like receptor 9 signaling
title_fullStr The mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: Inhibition of dendritic cell functions via Toll like receptor 9 signaling
title_full_unstemmed The mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: Inhibition of dendritic cell functions via Toll like receptor 9 signaling
title_short The mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: Inhibition of dendritic cell functions via Toll like receptor 9 signaling
title_sort mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: inhibition of dendritic cell functions via toll like receptor 9 signaling
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547638/
https://www.ncbi.nlm.nih.gov/pubmed/33049581
http://dx.doi.org/10.1016/j.biopha.2020.110848
work_keys_str_mv AT hanjiaochan themechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT lixing themechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT luoxiaoqing themechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT hejuan themechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT huangxuechan themechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT zhouqingyou themechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT hanyanping themechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT jiehongyu themechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT zhuangjian themechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT liyehao themechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT yangfangyuan themechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT zhaizeqing themechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT wushufan themechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT heyi themechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT yangbin themechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT sunerwei themechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT hanjiaochan mechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT lixing mechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT luoxiaoqing mechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT hejuan mechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT huangxuechan mechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT zhouqingyou mechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT hanyanping mechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT jiehongyu mechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT zhuangjian mechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT liyehao mechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT yangfangyuan mechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT zhaizeqing mechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT wushufan mechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT heyi mechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT yangbin mechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling
AT sunerwei mechanismsofhydroxychloroquineinrheumatoidarthritistreatmentinhibitionofdendriticcellfunctionsviatolllikereceptor9signaling